Extension Study for BAY43-9006 in Japanese Patients With Renal Cell Carcinoma [EXTENSION OF 700009408]

Trial Profile

Extension Study for BAY43-9006 in Japanese Patients With Renal Cell Carcinoma [EXTENSION OF 700009408]

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Mar 2014

At a glance

  • Drugs Sorafenib (Primary)
  • Indications Renal cell carcinoma
  • Focus Therapeutic Use
  • Sponsors Bayer
  • Most Recent Events

    • 24 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top